Literature DB >> 27141017

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

S Gillessen, A Omlin, G Attard, J S de Bono, E Efstathiou, K Fizazi, S Halabi, P S Nelson, O Sartor, M R Smith, H R Soule, H Akaza, T M Beer, H Beltran, A M Chinnaiyan, G Daugaard, I D Davis, M De Santis, C G Drake, R A Eeles, S Fanti, M E Gleave, A Heidenreich, M Hussain, N D James, F E Lecouvet, C J Logothetis, K Mastris, S Nilsson, W K Oh, D Olmos, A R Padhani, C Parker, M A Rubin, J A Schalken, H I Scher, A Sella, N D Shore, E J Small, C N Sternberg, H Suzuki, C J Sweeney, I F Tannock, B Tombal.   

Abstract

Entities:  

Year:  2016        PMID： 27141017     DOI： 10.1093/annonc/mdw180

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  10 in total

Review 1.  [Metastatic prostate cancer : Update: position paper for the use of chemotherapy].

Authors:  C-H Ohlmann; P J Goebell; M-O Grimm; J Klier; F König; S Machtens; M Schostak; A-J Schrader; P Albers
Journal:  Urologe A       Date:  2017-12       Impact factor: 0.639

Review 2.  Implications of the Fracture Risk Assessment Algorithm for the assessment and improvement of bone health in patients with prostate cancer: A comprehensive review.

Authors:  Ashish Sharma; Rahul Janak Sinha; Vishwajeet Singh; Gaurav Garg; Samarth Agarwal; Siddharth Pandey
Journal:  Turk J Urol       Date:  2019-02-20

Review 3.  Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223.

Authors:  A Rodriguez-Vida; M D Torregrosa; Á Pinto; M Á Climent; D Olmos; J Carles
Journal:  Clin Transl Oncol       Date:  2017-11-02       Impact factor: 3.405

4.  miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway.

Authors:  Jiafu Zhao; Houqiang Xu; Zhiqiang Duan; Xiang Chen; Zheng Ao; Yinglian Chen; Yong Ruan; Mengmeng Ni
Journal:  Cancer Manag Res       Date:  2020-07-31       Impact factor: 3.989

Review 5.  Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer.

Authors:  Christian Daniel Fankhauser; Cédric Poyet; Stephanie G C Kroeze; Benedikt Kranzbühler; Helena I Garcia Schüler; Matthias Guckenberger; Philipp A Kaufmann; Thomas Hermanns; Irene A Burger
Journal:  World J Urol       Date:  2018-07-20       Impact factor: 4.226

6.  Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer.

Authors:  Francesco Ceci; Lorenzo Bianchi; Marco Borghesi; Giulia Polverari; Andrea Farolfi; Alberto Briganti; Riccardo Schiavina; Eugenio Brunocilla; Paolo Castellucci; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-06       Impact factor: 9.236

7.  E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET.

Authors:  Francesco Ceci; Daniela E Oprea-Lager; Louise Emmett; Judit A Adam; Jamshed Bomanji; Johannes Czernin; Matthias Eiber; Uwe Haberkorn; Michael S Hofman; Thomas A Hope; Rakesh Kumar; Steven P Rowe; Sarah M Schwarzenboeck; Stefano Fanti; Ken Herrmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-19       Impact factor: 9.236

Review 8.  ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer.

Authors:  Karim Fizazi; Laurence Albiges; Yohann Loriot; Christophe Massard
Journal:  Expert Rev Anticancer Ther       Date:  2015       Impact factor: 4.512

9.  Relationship between serum lipid levels and ischemic stroke in patients with atrial fibrillation: a nested case-control study based on the China Atrial Fibrillation Registry.

Authors:  Fei Li; Xin Du; Liu He; Chao Jiang; Shijun Xia; Changsheng Ma; Jianzeng Dong
Journal:  BMC Cardiovasc Disord       Date:  2021-09-08       Impact factor: 2.298

10.  Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019).

Authors:  Maria Elena Lombardo; Elena Carraro; Cristina Sancricca; Michela Armando; Michela Catteruccia; Elena Mazzone; Giulia Ricci; Ferdinando Salamino; Filippo Maria Santorelli; Massimiliano Filosto
Journal:  Acta Myol       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.